You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 11, 2025

A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
Published on: August 14, 2018
Byeongwoon Song1, Olga Korolkova1
1Department of Microbiology, Immunology and Physiology, Center for AIDS Health Disparities Research, School of Medicine, Meharry Medical College, Nashville, TN 37208, USA.
Lysosome-targeting compounds, like bafilomycin A1, inhibit human immunodeficiency virus type 1 (HIV-1) replication by disrupting lysosomal cholesterol transport. This study reveals a novel mechanism impacting HIV-1 post-integration steps.
06:28Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
Published on: October 1, 2015
09:21Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
Published on: February 23, 2024
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: